Table 1.
Characteristics of the participants and clinical data in the pre- and post-AST periods.
| Characteristic | Total n = 264 (Patients) |
Pre-AST n = 208 (Episodes) |
Post-AST n = 311 (Episodes) |
p-Value |
|---|---|---|---|---|
| Age (years) | 72.5 (24.0–94.0) | 71.0 (24.0–94.0) | 71.0 (30.0–90.0) | 0.616 |
| Sex (male) | 157 (59.5) | 128 (61.5) | 167 (53.7) | 0.077 |
| BMI (kg/m2) | 20.7 (12.9–42.1) | 19.8 (12.9–40.0) | 20.9 (13.9–42.1) | <0.001 * |
| CKD † | 89 (33.7) | 96 (46.2) | 135 (43.4) | 0.537 |
| Diabetes mellitus | 31 (11.7) | 35 (16.8) | 23 (7.4) | 0.001 * |
| COPD | 7 (2.7) | 11 (5.3) | 4 (1.3) | 0.013 * |
| Hematologic disease | ||||
| Acute myeloid leukemia | 77 (29.2) | 69 (33.2) | 101 (32.5) | 0.868 |
| Myelodysplastic syndrome | 30 (11.4) | 23 (11.1) | 42 (13.5) | 0.409 |
| Acute lymphocytic leukemia | 10 (3.8) | 3 (1.4) | 20 (6.4) | 0.008 * |
| Malignant lymphoma | 84 (31.8) | 64 (30.8) | 91 (29.3) | 0.713 |
| Multiple myeloma | 21 (8.0) | 16 (7.7) | 26 (8.4) | 0.785 |
| Aplastic anemia | 8 (3.0) | 13 (6.3) | 12 (3.9) | 0.212 |
| Others | 34 (12.9) | 20 (9.6) | 19 (6.1) | 0.138 |
Number (%) or median (interquartile range). Abbreviations are as follows: BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease. † CKD was defined by eGFR of <60 mL/min/1.73 m2 as G3–G5 level as per the KDIGO guidelines. * p < 0.05.